Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Fursutiamine Market by Application (Food & Beverages, Animal Feed, Pharmaceuticals, Dietary Supplements, Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2022-2032

A50559

Pages: NA

Charts: NA

Tables: NA

Known as thiamine tetrahydrofurfuryl disulfide ( TTFD) or "Fursultiamine",is a synthetic derivative of thiamine (vitamin B1) that was first developed in Japan in the 1950s. It is believed to be more effective than thiamine because it can easily cross the blood-brain barrier, which allows it to reach the brain more easily and quickly than thiamine. Fursultiamine is commonly used as a nutritional supplement, particularly in Japan, to help support healthy brain function, energy metabolism, and nerve transmission. While some studies have suggested that fursultiamine may have benefits for certain conditions such as chronic fatigue syndrome, diabetic neuropathy, and Alzheimer's disease, more research is needed to fully understand its effects on human health.

It's important to note that fursultiamine should not be used as a substitute for a balanced and varied diet or for the treatment of medical conditions without consulting a healthcare professional. It is also worth noting that while fursultiamine is generally considered safe, it may cause side effects in some individuals, particularly when taken in high doses. Overall, fursultiamine is an interesting compound that shows potential for improving brain function and energy metabolism. However, more research is needed to fully understand its benefits and risks, and individuals should always consult with a healthcare professional before taking any dietary supplement.

With an increasing global population there is increasing concern about age-related cognitive decline and neurological disorders such as Alzheimer's disease. With the rise in aging populations worldwide, the demand for products that can support healthy brain function and cognitive performance has grown significantly in recent years. This has led to increased interest in dietary supplements that contain compounds like fursultiamine, which is believed to support healthy brain function. Fursultiamine is believed to enhance cognitive performance by supporting healthy nerve transmission and energy metabolism in the brain. It is also believed to help reduce inflammation and oxidative stress, which are two factors that can contribute to age-related cognitive decline and neurological disorders.

As a result, the demand for brain health supplements that contain fursultiamine has been on the rise. Consumers are increasingly interested in products that can help them maintain healthy cognitive function as they age, and fursultiamine has been studied for its potential to do just that.
 
In recent years, there has been a growing interest in natural and alternative medicine, as people seek out new ways to improve their health and well-being. This has led to an increase in demand for supplements that contain natural ingredients, such as fursultiamine. Fursultiamine is a synthetic derivative of thiamine, which is a naturally occurring vitamin. As a result, fursultiamine is often seen as a "natural" supplement that can help support overall health, particularly in the area of brain function and cognitive performance. One of the reasons for the growing interest in natural and alternative medicine is the desire to avoid the potential side effects and risks associated with prescription medications. Many people believe that natural supplements like fursultiamine are safer and have fewer side effects than traditional medications.

Fursultiamine is a water-soluble vitamin that is easily absorbed in the body. It makes an attractive supplement for those who prefer natural and alternative medicine. It is also believed to have a low toxicity profile, which further contributes to its perceived safety. Overall, the growing interest in natural and alternative medicine is expected to continue to drive the demand for supplements that contain natural ingredients like fursultiamine. However, it's important to note that more research is needed to fully understand the benefits and risks of fursultiamine, and individuals should always consult with a healthcare professional before taking any dietary supplement.

New product launches to flourish in the market
Double Wood Supplements - Fursultiamine (2021): Double Wood Supplements is a company that specializes in nootropics and dietary supplements. In 2021, they launched their own fursultiamine supplement, which is marketed as a cognitive enhancer and energy booster. Also, Pure Nootropics - Fursultiamine (2019): Pure Nootropics is a company that sells a variety of nootropic supplements, and they introduced their fursultiamine supplement in 2019. This product is designed to support mental clarity and focus, and it contains a high dose of fursultiamine. Moreover, research on fursultiamine and Alzheimer's disease (2019): In 2019, a study published in the Journal of Alzheimer's Disease found that fursultiamine may have neuroprotective effects that can help prevent the development of Alzheimer's disease. The study was conducted by researchers from the University of Sydney and the Australian National University. In addition, Science.bio - Fursultiamine (2018): Science.bio is a company that specializes in research chemicals and dietary supplements, and they introduced their fursultiamine supplement in 2018. This product is formulated with a high dose of fursultiamine and is marketed as a cognitive enhancer and energy booster.

Segment Overview: 
By Application: The fursultiamine market is divided into food and beverages, animal feed, pharmaceuticals    Dietary Supplements and Others. Fursultiamine can be used as a food additive or fortifier, and it is sometimes added to functional food and beverage products that are marketed for their cognitive or energy-boosting benefits. 
Moreover, fursultiamine     is also used as an ingredient in animal feed, as it is believed to have benefits for animal health and productivity. In pharmaceuticals fursultiamine is used in some pharmaceutical formulations, particularly in Japan and other Asian countries, as a treatment for thiamine deficiency and related conditions. Moreover, in dietary supplements, fursultiamine is widely available as a dietary supplement, and it is marketed as a nootropic or cognitive enhancer that can help support healthy brain function.

In some cases, the  fursultiamine market sub-segmentmay also include other products and applications,such as cosmetics or personal care products formulated with fursultiamine.
 
By Distribution Channel: The fursultiamine market is divided into retail pharmacies, hospital pharmacies and online pharmacies. While retail pharmacies and online pharmacies are common distribution channels for fursultiamine supplements and products, it's important to note that fursultiamine is not typically sold or prescribed through hospital pharmacies. Hospitals primarily dispense medication to patients who are being treated in the hospital, and fursultiamine is not commonly used as a hospital medication. Moreover, the fursultiamine market can be segmented by distribution channel, and retail pharmacies and online pharmacies are two common channels for the distribution of fursultiamine supplements and related products. Other distribution channels may include specialty health stores, direct-to-consumer sales, and through healthcare practitioners such as doctors or nutritionists. 
 
By Region: The Asia Pacific fursultiamine market is indeed one of the fastest-growing markets in the world, with significant growth expected in the coming years due to several factors. Fursultiamine is a vitamin B1 derivative that is primarily used as a dietary supplement, and it is believed to support brain health and cognitive function. One key factor driving the growth of the fursultiamine market in the Asia Pacific region is the increasing awareness of the potential health benefits of this supplement. As the population in the region continues to age, there is growing concern about age-related cognitive decline and neurological disorders such as Alzheimer's disease. Fursultiamine is believed to help support healthy brain function, which has led to increased demand for supplements that contain this compound.
 
Another factor driving the growth of the fursultiamine market in the Asia Pacific region is the growing interest in natural and alternative health supplements. Many people in the region are turning to natural and alternative medicine to improve their health and well-being, and fursultiamine is seen as a "natural" supplement that can help support overall health. Rising disposable incomes in many countries in the Asia Pacific region are also contributing to the growth of the fursultiamine market. As more people have disposable income, they are more likely to spend money on health supplements and products, including those that support brain health and cognitive function.
 
Asia Pacific region is home to large and rapidly growing economies, including China, India, and Japan, which are key markets for fursultiamine supplements and related products. These countries have a large population and a growing middle class, which provide a significant customer base for health supplements.

Competitive analysis and profiles of the major players in the fursultiamine market: -
DSM  Nutricost, Jiangxi Tianxin Pharmaceutical Co., Ltd., Chemizo Enterprise, and Xinfa Pharmaceutical Co., Ltd. McCartan’s Pharmacy, Jiangsu Jubang Pharmaceutical Co., Ltd., and HPC are included in the report. Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the fursultiamine market.     

Key Market Segments

  • By Application
    • Food & Beverages
    • Animal Feed
    • Pharmaceuticals
    • Dietary Supplements
    • Others
  • By Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA


Key Market Players

  • McCartan’s Pharmacy
  • Jiangxi Tianxin Pharmaceutical Co., Ltd.
  • Nutricost
  • Chemizo Enterprise
  • HPC
  • Xinfa Pharmaceutical Co., Ltd.
  • DSM
  • Jiangsu Jubang Pharmaceutical Co., Ltd.

TABLE OF CONTENTS

  • CHAPTER 1:    INTRODUCTION

    • 1.1.   Report description

    • 1.2.   Key benefits for stakeholders

    • 1.3.   Key market segments

    • 1.4.   Research methodology

      • 1.4.1.   Primary research

      • 1.4.2.   Secondary research

      • 1.4.3.   Analyst tools and models

    CHAPTER 2:    EXECUTIVE SUMMARY

    • 2.1.   Key findings of the study

    • 2.2.   CXO perspective

    CHAPTER 3:    MARKET OVERVIEW

    • 3.1.   Market definition and scope

    • 3.2.   Key findings

      • 3.2.1.   Top investment pockets

      • 3.2.2.   Top wining strategies

    • 3.3.   Porter’s five forces analysis

    • 3.4.   Top player positioning/Market share analysis

    • 3.5.   Market dynamics

      • 3.5.1.   Drivers

      • 3.5.2.   Restraint

      • 3.5.3.   Opportunity

    • 3.6.   COVID-19 Impact Analysis

  • CHAPTER 4 : FURSUTIAMINE , BY APPLICATION

    • 4.1.   Overview

      • 4.1.1 Market size and forecast, by application

    • 4.2.   Food & Beverages

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis, by country

    • 4.3.   Animal Feed

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis, by country

    • 4.4.   Pharmaceuticals

      • 4.4.1. Key market trends, growth factors and opportunities

      • 4.4.2. Market size and forecast, by region

      • 4.4.3. Market share analysis, by country

    • 4.5.   Dietary Supplements

      • 4.5.1. Key market trends, growth factors and opportunities

      • 4.5.2. Market size and forecast, by region

      • 4.5.3. Market share analysis, by country

    • 4.6.   Others

      • 4.6.1. Key market trends, growth factors and opportunities

      • 4.6.2. Market size and forecast, by region

      • 4.6.3. Market share analysis, by country

  • CHAPTER 5 : FURSUTIAMINE , BY DISTRIBUTION CHANNEL

    • 5.1.   Overview

      • 5.1.1 Market size and forecast, by distribution channel

    • 5.2.   Retail Pharmacies

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis, by country

    • 5.3.   Hospital Pharmacies

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis, by country

    • 5.4.   Online Pharmacies

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis, by country

  • CHAPTER 6 : FURSUTIAMINE , BY REGIONS

    • 6.1.  Overview

    • 6.2.  NORTH AMERICA

      • 6.2.1. Key market trends, growth factors, and opportunities

      • 6.2.2. Market size and forecast, by application

      • 6.2.3. Market size and forecast, by distribution channel

      • 6.2.4. Market size and forecast, by country

      • 6.2.5. U.S.

        • 6.2.5.1. Key market trends, growth factors, and opportunities

        • 6.2.5.2 Market size and forecast, by application

        • 6.2.5.3 Market size and forecast, by distribution channel

      • 6.2.6. Canada

        • 6.2.6.1. Key market trends, growth factors, and opportunities

        • 6.2.6.2 Market size and forecast, by application

        • 6.2.6.3 Market size and forecast, by distribution channel

      • 6.2.7. Mexico

        • 6.2.7.1. Key market trends, growth factors, and opportunities

        • 6.2.7.2 Market size and forecast, by application

        • 6.2.7.3 Market size and forecast, by distribution channel

    • 6.3.  EUROPE

      • 6.3.1. Key market trends, growth factors, and opportunities

      • 6.3.2. Market size and forecast, by application

      • 6.3.3. Market size and forecast, by distribution channel

      • 6.3.4. Market size and forecast, by country

      • 6.3.5. France

        • 6.3.5.1. Key market trends, growth factors, and opportunities

        • 6.3.5.2 Market size and forecast, by application

        • 6.3.5.3 Market size and forecast, by distribution channel

      • 6.3.6. Germany

        • 6.3.6.1. Key market trends, growth factors, and opportunities

        • 6.3.6.2 Market size and forecast, by application

        • 6.3.6.3 Market size and forecast, by distribution channel

      • 6.3.7. Italy

        • 6.3.7.1. Key market trends, growth factors, and opportunities

        • 6.3.7.2 Market size and forecast, by application

        • 6.3.7.3 Market size and forecast, by distribution channel

      • 6.3.8. Spain

        • 6.3.8.1. Key market trends, growth factors, and opportunities

        • 6.3.8.2 Market size and forecast, by application

        • 6.3.8.3 Market size and forecast, by distribution channel

      • 6.3.9. UK

        • 6.3.9.1. Key market trends, growth factors, and opportunities

        • 6.3.9.2 Market size and forecast, by application

        • 6.3.9.3 Market size and forecast, by distribution channel

      • 6.3.10. Russia

        • 6.3.10.1. Key market trends, growth factors, and opportunities

        • 6.3.10.2 Market size and forecast, by application

        • 6.3.10.3 Market size and forecast, by distribution channel

      • 6.3.11. Rest of Europe

        • 6.3.11.1. Key market trends, growth factors, and opportunities

        • 6.3.11.2 Market size and forecast, by application

        • 6.3.11.3 Market size and forecast, by distribution channel

    • 6.4.  ASIA-PACIFIC

      • 6.4.1. Key market trends, growth factors, and opportunities

      • 6.4.2. Market size and forecast, by application

      • 6.4.3. Market size and forecast, by distribution channel

      • 6.4.4. Market size and forecast, by country

      • 6.4.5. China

        • 6.4.5.1. Key market trends, growth factors, and opportunities

        • 6.4.5.2 Market size and forecast, by application

        • 6.4.5.3 Market size and forecast, by distribution channel

      • 6.4.6. Japan

        • 6.4.6.1. Key market trends, growth factors, and opportunities

        • 6.4.6.2 Market size and forecast, by application

        • 6.4.6.3 Market size and forecast, by distribution channel

      • 6.4.7. India

        • 6.4.7.1. Key market trends, growth factors, and opportunities

        • 6.4.7.2 Market size and forecast, by application

        • 6.4.7.3 Market size and forecast, by distribution channel

      • 6.4.8. South Korea

        • 6.4.8.1. Key market trends, growth factors, and opportunities

        • 6.4.8.2 Market size and forecast, by application

        • 6.4.8.3 Market size and forecast, by distribution channel

      • 6.4.9. Australia

        • 6.4.9.1. Key market trends, growth factors, and opportunities

        • 6.4.9.2 Market size and forecast, by application

        • 6.4.9.3 Market size and forecast, by distribution channel

      • 6.4.10. Thailand

        • 6.4.10.1. Key market trends, growth factors, and opportunities

        • 6.4.10.2 Market size and forecast, by application

        • 6.4.10.3 Market size and forecast, by distribution channel

      • 6.4.11. Malaysia

        • 6.4.11.1. Key market trends, growth factors, and opportunities

        • 6.4.11.2 Market size and forecast, by application

        • 6.4.11.3 Market size and forecast, by distribution channel

      • 6.4.12. Indonesia

        • 6.4.12.1. Key market trends, growth factors, and opportunities

        • 6.4.12.2 Market size and forecast, by application

        • 6.4.12.3 Market size and forecast, by distribution channel

      • 6.4.13. Rest of Asia-Pacific

        • 6.4.13.1. Key market trends, growth factors, and opportunities

        • 6.4.13.2 Market size and forecast, by application

        • 6.4.13.3 Market size and forecast, by distribution channel

    • 6.5.  LAMEA

      • 6.5.1. Key market trends, growth factors, and opportunities

      • 6.5.2. Market size and forecast, by application

      • 6.5.3. Market size and forecast, by distribution channel

      • 6.5.4. Market size and forecast, by country

      • 6.5.5. Brazil

        • 6.5.5.1. Key market trends, growth factors, and opportunities

        • 6.5.5.2 Market size and forecast, by application

        • 6.5.5.3 Market size and forecast, by distribution channel

      • 6.5.6. South Africa

        • 6.5.6.1. Key market trends, growth factors, and opportunities

        • 6.5.6.2 Market size and forecast, by application

        • 6.5.6.3 Market size and forecast, by distribution channel

      • 6.5.7. Saudi Arabia

        • 6.5.7.1. Key market trends, growth factors, and opportunities

        • 6.5.7.2 Market size and forecast, by application

        • 6.5.7.3 Market size and forecast, by distribution channel

      • 6.5.8. UAE

        • 6.5.8.1. Key market trends, growth factors, and opportunities

        • 6.5.8.2 Market size and forecast, by application

        • 6.5.8.3 Market size and forecast, by distribution channel

      • 6.5.9. Argentina

        • 6.5.9.1. Key market trends, growth factors, and opportunities

        • 6.5.9.2 Market size and forecast, by application

        • 6.5.9.3 Market size and forecast, by distribution channel

      • 6.5.10. Rest of LAMEA

        • 6.5.10.1. Key market trends, growth factors, and opportunities

        • 6.5.10.2 Market size and forecast, by application

        • 6.5.10.3 Market size and forecast, by distribution channel

  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2022

  • CHAPTER 8 : COMPANY PROFILES

    • 8.1. DSM

      • 8.1.1. Company overview

      • 8.1.2. Business performance

      • 8.1.3. Key strategic moves and developments

    • 8.2. NUTRICOST

      • 8.2.1. Company overview

      • 8.2.2. Business performance

      • 8.2.3. Key strategic moves and developments

    • 8.3. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.

      • 8.3.1. Company overview

      • 8.3.2. Business performance

      • 8.3.3. Key strategic moves and developments

    • 8.4. CHEMIZO ENTERPRISE

      • 8.4.1. Company overview

      • 8.4.2. Business performance

      • 8.4.3. Key strategic moves and developments

    • 8.5. XINFA PHARMACEUTICAL CO., LTD.

      • 8.5.1. Company overview

      • 8.5.2. Business performance

      • 8.5.3. Key strategic moves and developments

    • 8.6. MCCARTAN’S PHARMACY

      • 8.6.1. Company overview

      • 8.6.2. Business performance

      • 8.6.3. Key strategic moves and developments

    • 8.7. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.

      • 8.7.1. Company overview

      • 8.7.2. Business performance

      • 8.7.3. Key strategic moves and developments

    • 8.8. HPC

      • 8.8.1. Company overview

      • 8.8.2. Business performance

      • 8.8.3. Key strategic moves and developments

    • 8.9. COMPANY 9

      • 8.9.1. Company overview

      • 8.9.2. Business performance

      • 8.9.3. Key strategic moves and developments

    • 8.10. COMPANY 10

      • 8.10.1. Company overview

      • 8.10.2. Business performance

      • 8.10.3. Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL FURSUTIAMINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL FURSUTIAMINE MARKET FOR FOOD AND BEVERAGES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL FURSUTIAMINE MARKET FOR FOOD AND BEVERAGES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL FURSUTIAMINE MARKET FOR ANIMAL FEED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL FURSUTIAMINE MARKET FOR ANIMAL FEED, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL FURSUTIAMINE MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL FURSUTIAMINE MARKET FOR PHARMACEUTICALS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL FURSUTIAMINE MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL FURSUTIAMINE MARKET FOR DIETARY SUPPLEMENTS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL FURSUTIAMINE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL FURSUTIAMINE MARKET FOR OTHERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL FURSUTIAMINE MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL FURSUTIAMINE MARKET FOR RETAIL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL FURSUTIAMINE MARKET FOR RETAIL PHARMACIES, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL FURSUTIAMINE MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL FURSUTIAMINE MARKET FOR HOSPITAL PHARMACIES, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL FURSUTIAMINE MARKET FOR ONLINE PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL FURSUTIAMINE MARKET FOR ONLINE PHARMACIES, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL FURSUTIAMINE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA FURSUTIAMINE, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 25. EUROPE FURSUTIAMINE, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 28. REST OF EUROPE FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. REST OF EUROPE FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 30. ASIA-PACIFIC FURSUTIAMINE, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. ASIA-PACIFIC FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. ASIA-PACIFIC FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 33. REST OF ASIA-PACIFIC FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. REST OF ASIA-PACIFIC FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 35. LAMEA FURSUTIAMINE, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. LAMEA FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. LAMEA FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 38. REST OF LAMEA FURSUTIAMINE, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. REST OF LAMEA FURSUTIAMINE, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 40. DSM: KEY EXECUTIVES
  • TABLE 41. DSM: COMPANY SNAPSHOT
  • TABLE 42. DSM: OPERATING SEGMENTS
  • TABLE 43. DSM: PRODUCT PORTFOLIO
  • TABLE 44. DSM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 45. NUTRICOST: KEY EXECUTIVES
  • TABLE 46. NUTRICOST: COMPANY SNAPSHOT
  • TABLE 47. NUTRICOST: OPERATING SEGMENTS
  • TABLE 48. NUTRICOST: PRODUCT PORTFOLIO
  • TABLE 49. NUTRICOST: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 50. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 51. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 52. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 53. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 54. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 55. CHEMIZO ENTERPRISE: KEY EXECUTIVES
  • TABLE 56. CHEMIZO ENTERPRISE: COMPANY SNAPSHOT
  • TABLE 57. CHEMIZO ENTERPRISE: OPERATING SEGMENTS
  • TABLE 58. CHEMIZO ENTERPRISE: PRODUCT PORTFOLIO
  • TABLE 59. CHEMIZO ENTERPRISE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 60. XINFA PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 61. XINFA PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 62. XINFA PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 63. XINFA PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 64. XINFA PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 65. MCCARTAN’S PHARMACY: KEY EXECUTIVES
  • TABLE 66. MCCARTAN’S PHARMACY: COMPANY SNAPSHOT
  • TABLE 67. MCCARTAN’S PHARMACY: OPERATING SEGMENTS
  • TABLE 68. MCCARTAN’S PHARMACY: PRODUCT PORTFOLIO
  • TABLE 69. MCCARTAN’S PHARMACY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 70. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: KEY EXECUTIVES
  • TABLE 71. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT
  • TABLE 72. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: OPERATING SEGMENTS
  • TABLE 73. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 74. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 75. HPC: KEY EXECUTIVES
  • TABLE 76. HPC: COMPANY SNAPSHOT
  • TABLE 77. HPC: OPERATING SEGMENTS
  • TABLE 78. HPC: PRODUCT PORTFOLIO
  • TABLE 79. HPC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. COMPANY 9: KEY EXECUTIVES
  • TABLE 81. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 82. COMPANY 9: OPERATING SEGMENTS
  • TABLE 83. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 84. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. COMPANY 10: KEY EXECUTIVES
  • TABLE 86. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 87. COMPANY 10: OPERATING SEGMENTS
  • TABLE 88. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 89. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL FURSUTIAMINE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL FURSUTIAMINE MARKET
  • FIGURE 3. SEGMENTATION FURSUTIAMINE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN FURSUTIAMINE MARKET
  • FIGURE 5. TOP WINNING STRATEGIES, 2020-2022*
  • FIGURE 6. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*(%)
  • FIGURE 7. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 8. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 9. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 10. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 10. LOW THREAT OF SUBSTITUTION
  • FIGURE 11. HIGH COMPETITIVE RIVALRY
  • FIGURE 12. TOP PLAYER POSITIONING, 2022
  • FIGURE 13. MARKET SHARE ANALYSIS, 2022
  • FIGURE 14. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALFURSUTIAMINE MARKET
  • FIGURE 15. FURSUTIAMINE MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 16. FURSUTIAMINE MARKET FOR FOOD AND BEVERAGES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. FURSUTIAMINE MARKET FOR ANIMAL FEED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. FURSUTIAMINE MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. FURSUTIAMINE MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. FURSUTIAMINE MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. FURSUTIAMINE MARKET SEGMENTATION, BY DISTRIBUTION CHANNEL
  • FIGURE 22. FURSUTIAMINE MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. FURSUTIAMINE MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. FURSUTIAMINE MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. DSM: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 26. DSM: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 27. DSM: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 28. NUTRICOST: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. NUTRICOST: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. NUTRICOST: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. JIANGXI TIANXIN PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. CHEMIZO ENTERPRISE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. CHEMIZO ENTERPRISE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. CHEMIZO ENTERPRISE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. XINFA PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. XINFA PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. XINFA PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. MCCARTAN’S PHARMACY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. MCCARTAN’S PHARMACY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. MCCARTAN’S PHARMACY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. JIANGSU JUBANG PHARMACEUTICAL CO., LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. HPC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. HPC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. HPC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

Purchase Full Report of
Fursutiamine Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue